Detailed price information for Agios Pharmaceuticals (AGIO-Q) from The Globe and Mail including charting and trades.

Bristol Myers Squibb (BMY) stock slips as its anemia drug Reblozyl misses primary goal in a Phase 3 trial for myelofibrosis, ...

Despite a phase 3 flop, Bristol Myers Squibb—encouraged by “clinically meaningful results” and bruised by three other recent ...

PGIM Jennison Health Sciences Fund released its first quarter 2025 investor letter. A copy of the letter can be downloaded ...

A Northeast Ohio woman and a 22-year-old man from UAE are among the first patients to receive the innovative CRISPR treatment.

Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...

Bone marrow transplant offers a potential cure for thalassemia by replacing the faulty blood-forming stem cells with healthy ...

"Vertex reports long-term results for Casgevy in sickle cell and thalassaemia" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

The biopharma—which is in the process of launching its approved sickle cell disease and beta thalassemia gene therapy Casgevy—has also recently shifted away from adeno-associated virus vectors ...

While the ‌iOS 26‌ and ‌iPadOS 26‌ betas are limited to developers right now, Apple plans to release a public beta in July. The updates will launch in the fall.

Columnist Oluwatosin Adesoye, a doctor, sorts through the difference between sickle cell anemia and sickle cell disease — and ...